Figure 6 - CuFe@DMSA.jpg

One of the most important projects of my Ph.D. thesis was the implementation of an inorganic nanomaterial, based on copper and iron, for its use as antitumoral therapy. This work was performed alongside my coworker, who was responsible of the chemical synthesis and characterization of the nanomaterial. Overall, this work was developed from the full synthesis of the nanomaterial to its administration to laboratory animals as an anitumotal therapy.

In particular, the series of experiments that I conducted allowed us to gain the following insights:

This collaborative work allowed me to strenghten some attitudes such as teamwork with an interdisciplinary team, results presentation, data treatment, paying attention to details, and evidence-based problem solving. Moreover, the results of this project led to the publication of several scientific articles in Q1 journals, generating extremely interesting scientific insights:

  1. Encinas-Gimenez, M.; Martín-Pardillos, A.; Bonet-Aleta, J.; Pérez, E.; Rodríguez-Largo, A.; Hueso, J. L.; Santamaria, J.; Martin-Duque, P. Unravelling the Cell Death Mechanism Triggered by Catalytic Copper–Iron Nanoparticles in Vitro and in Vivo. Nanoscale 2025, 17 (37), 21614–21630.
  2. Bonet-Aleta, J.; Alegre-Requena, J. V.; Martin-Martin, J.; Encinas-Gimenez, M.; Martín-Pardillos, A.; Martin-Duque, P.; Hueso, J. L.; Santamaria, J. Nanoparticle-Catalyzed Transamination under Tumor Microenvironment Conditions: A Novel Tool to Disrupt the Pool of Amino Acids and GSSG in Cancer Cells. Nano Letters 2024, 24 (14), 4091–4100.
  3. Bonet-Aleta, J.;  Encinas-Gimenez, M.;  Urriolabeitia, E.;  Martin-Duque, P.;  Hueso, J. L.; Santamaria, J., Unveiling the interplay between homogeneous and heterogeneous catalytic mechanisms in copper-iron nanoparticles working under chemically relevant tumor conditions. Chem Sci 2022, 13 (28), 8307-8320.